title: FDA given new powers over data reporting to national clinical trials registry.
authors.forename: Bob
authors.initials: B
authors.lastname: Roehr
mesh_terms: D002017:Budgets / Q000331:legislation & jurisprudence; D026661:Clinical Trials Data Monitoring Committees / Q000191:economics / Q000331:legislation & jurisprudence*; D002986:Clinical Trials as Topic / Q000191:economics / Q000331:legislation & jurisprudence*; D019992:Databases as Topic / Q000191:economics / Q000331:legislation & jurisprudence; D017277:Drug Approval / Q000191:economics / Q000331:legislation & jurisprudence; D005380:Financing, Government / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D009317:National Library of Medicine (U.S.) / Q000191:economics / Q000331:legislation & jurisprudence; D012042:Registries; D012107:Research Design / Q000331:legislation & jurisprudence*; D012941:Social Responsibility; D014481:United States; D014486:United States Food and Drug Administration / Q000191:economics / Q000331:legislation & jurisprudence*